Research Published December 2015 and January 2016

By |2016-10-21T17:14:08-05:00February 10th, 2016|Categories: DSF Research Review|

Clinical Research: Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. (Lancet Neurology, Dec. 2015) ( Data from the first large safety and tolerability study on GW Pharmaceuticals’ Epidiolex, a highly purified extraction of plant-based cannabidiol (CBD), was published. The study, led by Dr. Orrin Devinsky and clinicians across the US, included 214 patients, 33 [...]